Drugs / OSIRIS
last change Dec 2010 re-read 3 minutes ago

OSIRIS

Developed for
allergic rhinitis

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 2 NCT01240954 Comparator Dec 2010 → ? allergic rhinitis ALK-Abelló A/S Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as OSIRIS ClinicalTrials.gov intervention name — accepted as the source's own label NCT01240954 ↗